Is a complete ONCO research report available?

No complete published report is available for Onconetix, Inc. (ONCO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Onconetix, Inc. (ONCO)

NASDAQ: ONCO · USD

$0.58

+0.11 (+22.5%)· Recorded snapshot

Market cap	2.3M
Revenue (ttm)	645.8K
Net income (ttm)	-10.2M
EPS (ttm)	-$17.2
Shares out	3.9M
Volume	44,150,566
Beta	2.61

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 645.8K
Net income (ttm): -10.2M
EPS (ttm): -$17.2
Market cap: 2.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Metric	Value
Amount currency	USD
CIK code	0001782107
Company name	Onconetix, Inc.
Country	United States
Country code	US
CUSIP number	68237Q401
Earnings date	2026-11-12
Earnings time	amc
Employees	2
Employees change	-3
Employees growth	-60%
Enterprise value	$-3.5M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2018
Industry	Biotechnology
IPO date	2022-02-18
Is primary listing	Yes
Is SPAC	No
ISIN number	US68237Q4010
Last 10-K release date	2026-03-13
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split date	2026-05-21
Last stock split type	Reverse
Market cap	$2.3M
Market cap category	Nano-Cap
Next earnings date	2026-11-12
Options	No
Price	$0.58
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ONCO
U.S. state	Ohio
Website	https://www.onconetix.com

Metric

Value

Amount currency

USD

CIK code

0001782107

Company name

Onconetix, Inc.

Country

United States

Country code

CUSIP number

68237Q401

Earnings date

2026-11-12

Earnings time

amc

Employees

Employees change

-3

Employees growth

-60%

Enterprise value

$-3.5M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2018

Industry

Biotechnology

IPO date

2022-02-18

Is primary listing

Yes

Is SPAC

ISIN number

US68237Q4010

Last 10-K release date

2026-03-13

Last earnings date

2026-08-13

Last refreshed

2026-10-28

Last stock split date

2026-05-21

Last stock split type

Reverse

Market cap

$2.3M

Market cap category

Nano-Cap

Next earnings date

2026-11-12

Options

Price

$0.58

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

ONCO

U.S. state

Ohio

Website

https://www.onconetix.com

Metric	Value
Earnings yield	-2,950.27%
FCF / EV yield	312.93%
FCF yield	-418.84%
P/B ratio	0.13x
P/S ratio	3.81x
Price / tangible book value	0.64x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-2,950.27%

FCF / EV yield

312.93%

FCF yield

-418.84%

P/B ratio

0.13x

P/S ratio

3.81x

Price / tangible book value

0.64x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Gross margin	80.4%
Operating margin	-1,190.29%
Pretax margin	-1,578.71%
Profit per employee	$-5.1M
Revenue per employee	$322,912
ROA	-27.03%
ROA (5Y)	-31.17%
ROCE	-57.02%
ROE	-105.23%
ROE (5Y)	-366.64%
ROIC	-33.93%
SBC / revenue	6.77%
Tax / revenue	0.08%

Metric

Value

Gross margin

80.4%

Operating margin

-1,190.29%

Pretax margin

-1,578.71%

Profit per employee

$-5.1M

Revenue per employee

$322,912

ROA

-27.03%

ROA (5Y)

-31.17%

ROCE

-57.02%

ROE

-105.23%

ROE (5Y)

-366.64%

ROIC

-33.93%

SBC / revenue

6.77%

Tax / revenue

0.08%

Metric	Value
EPS growth quarters	2
EPS growth years	2
Gross profit growth	-41.11%
Gross profit growth (Q)	-93.9%
Net income growth years	1
Revenue growth	-51.33%
Revenue growth (Q)	-83.92%
Revenue growth (QoQ)	-20.21%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

-41.11%

Gross profit growth (Q)

-93.9%

Net income growth years

Revenue growth

-51.33%

Revenue growth (Q)

-83.92%

Revenue growth (QoQ)

-20.21%

Revenue growth years

Metric	Value
Depreciation and amortization	$14,753
EBIT	$-7.7M
EBITDA	$-7.7M
EPS	$-17.16
FCF per share	$-2.61
Financing cash flow	$15.6M
Free cash flow	$-10.3M
Free cash flow minus SBC	$-10.4M
Gross profit	$519,226
Income taxes	$525
Net borrowing	$-4.6M
Net cash flow	$5.7M
Net income	$-10.2M
Operating cash flow minus SBC	$-10.4M
Operating income	$-7.7M
Revenue	$645,824
Stock-based compensation	$43,693

Metric

Value

Depreciation and amortization

$14,753

EBIT

$-7.7M

EBITDA

$-7.7M

EPS

$-17.16

FCF per share

$-2.61

Financing cash flow

$15.6M

Free cash flow

$-10.3M

Free cash flow minus SBC

$-10.4M

Gross profit

$519,226

Income taxes

$525

Net borrowing

$-4.6M

Net cash flow

$5.7M

Net income

$-10.2M

Operating cash flow minus SBC

$-10.4M

Operating income

$-7.7M

Revenue

$645,824

Stock-based compensation

$43,693

Metric	Value
Altman Z-Score	-12.46
Book value per share	$3.55
Debt / equity	0.01
Goodwill	$9.6M
Interest coverage	-24.72
Long-term assets	$9.9M
Long-term liabilities	$14,039
Net cash (debt)	$5.8M
Net cash / market cap	233.85%
Net debt / equity	-0.43
Piotroski F-Score	3
Property, plant and equipment	$65,389
Shareholders' equity	$13.5M
Tangible book value	$3.9M
Tangible book value per share	$1.01
Total assets	$16.4M
Total cash	$5.9M
Total debt	$187,128
Total liabilities	$3M
WACC	26.55%

Metric

Value

Altman Z-Score

-12.46

Book value per share

$3.55

Debt / equity

0.01

Goodwill

$9.6M

Interest coverage

-24.72

Long-term assets

$9.9M

Long-term liabilities

$14,039

Net cash (debt)

$5.8M

Net cash / market cap

233.85%

Net debt / equity

-0.43

Piotroski F-Score

Property, plant and equipment

$65,389

Shareholders' equity

$13.5M

Tangible book value

$3.9M

Tangible book value per share

$1.01

Total assets

$16.4M

Total cash

$5.9M

Total debt

$187,128

Total liabilities

$3M

WACC

26.55%

Metric	Value
Asset turnover	0.04
Current assets	$6.5M
Current liabilities	$2.9M
Current ratio	2.21
Inventory turnover	0.7
Net working capital	$-2.2M
Quick ratio	2.04
Working capital	$3.6M
Working capital turnover	-0.16

Metric

Value

Asset turnover

0.04

Current assets

$6.5M

Current liabilities

$2.9M

Current ratio

2.21

Inventory turnover

0.7

Net working capital

$-2.2M

Quick ratio

2.04

Working capital

$3.6M

Working capital turnover

-0.16

Metric	Value
Dividend yield	0%

Metric

Value

Dividend yield

Metric	Value
150-day SMA	$2.86
1D price change	22.52%
1M price change	-40.8%
1M total return	-40.8%
1W price change	50.05%
1W total return	50.05%
1Y price change	-99.66%
1Y return CAGR	-99.66%
1Y total return	-99.66%
20-day SMA	$0.55
200-day SMA	$14.65
3M price change	-25.08%
3M total return	-25.08%
3Y price change	-100%
3Y return CAGR	-97.78%
3Y total return	-100%
50-day SMA	$0.67
50-day SMA vs 200-day SMA	50under200
52-week high	$200.00
52-week high date	2025-10-30
52-week low	$0.34
52-week low date	2026-10-27
6M price change	-91.78%
6M total return	-91.78%
After-hours change	2.75%
After-hours close	$0.58
After-hours price	$0.60
All-time high	$15,452,876.38
All-time high date	2022-02-22
All-time low	$0.34
All-time low date	2026-10-27
Average true range (ATR)	$0.10
Average volume	5.1M
Beta (1Y)	0.72
Beta (2Y)	1.91
Beta (5Y)	2.61
Change from 52-week high	-99.71%
Change from 52-week low	69.88%
Change from all-time high	-100%
Change from all-time low	78.15%
Change from open	14.31%
Day's gap	7.18%
Dollar volume	$25.7M
High price	$0.67
Low price	$0.50
Monthly RSI	13.9
Open price	$0.51
Position in 52-week range	46.71%
Premarket change	7.4%
Premarket close	$0.47
Premarket price	$0.51
Premarket volume	402K
Previous close	$0.47
Price vs 150-day SMA	-78.69%
Price vs 20-day SMA	11.03%
Price vs 200-day SMA	-95.84%
Price vs 50-day SMA	-8.3%
Relative volume	8.63
Return from IPO open	-100%
Return from IPO price	-93.08%
RSI	52.2
Sharpe ratio	-2.32
Sharpe ratio (3Y)	-1.3
Sortino ratio	-2.95
Sortino ratio (3Y)	-2.03
Volume	44.2M
Weekly RSI	28.92
YTD price change	-99.22%
YTD total return	-99.22%

Metric

Value

150-day SMA

$2.86

1D price change

22.52%

1M price change

-40.8%

1M total return

-40.8%

1W price change

50.05%

1W total return

50.05%

1Y price change

-99.66%

1Y return CAGR

-99.66%

1Y total return

-99.66%

20-day SMA

$0.55

200-day SMA

$14.65

3M price change

-25.08%

3M total return

-25.08%

3Y price change

-100%

3Y return CAGR

-97.78%

3Y total return

-100%

50-day SMA

$0.67

50-day SMA vs 200-day SMA

50under200

52-week high

$200.00

52-week high date

2025-10-30

52-week low

$0.34

52-week low date

2026-10-27

6M price change

-91.78%

6M total return

-91.78%

After-hours change

2.75%

After-hours close

$0.58

After-hours price

$0.60

All-time high

$15,452,876.38

All-time high date

2022-02-22

All-time low

$0.34

All-time low date

2026-10-27

Average true range (ATR)

$0.10

Average volume

5.1M

Beta (1Y)

0.72

Beta (2Y)

1.91

Beta (5Y)

2.61

Change from 52-week high

-99.71%

Change from 52-week low

69.88%

Change from all-time high

-100%

Change from all-time low

78.15%

Change from open

14.31%

Day's gap

7.18%

Dollar volume

$25.7M

High price

$0.67

Low price

$0.50

Monthly RSI

13.9

Open price

$0.51

Position in 52-week range

46.71%

Premarket change

7.4%

Premarket close

$0.47

Premarket price

$0.51

Premarket volume

402K

Previous close

$0.47

Price vs 150-day SMA

-78.69%

Price vs 20-day SMA

11.03%

Price vs 200-day SMA

-95.84%

Price vs 50-day SMA

-8.3%

Relative volume

8.63

Return from IPO open

-100%

Return from IPO price

-93.08%

RSI

52.2

Sharpe ratio

-2.32

Sharpe ratio (3Y)

-1.3

Sortino ratio

-2.95

Sortino ratio (3Y)

-2.03

Volume

44.2M

Weekly RSI

28.92

YTD price change

-99.22%

YTD total return

-99.22%

Metric	Value
Float	3.9M
Float percentage	100%
Shares change (QoQ)	3,468.28%
Shares held by insiders	0%
Shares held by institutions	7.39%
Shares outstanding	3.9M
Short % of float	12.4%
Short % of shares	12.4%
Short ratio	0.1 days

Metric

Value

Float

3.9M

Float percentage

100%

Shares change (QoQ)

3,468.28%

Shares held by insiders

Shares held by institutions

7.39%

Shares outstanding

3.9M

Short % of float

12.4%

Short % of shares

12.4%

Short ratio

0.1 days

Metric	Value
Page views	367

Metric

Value

Page views

367

Onconetix, Inc. (ONCO)

Price

Financial snapshot

Fair-value bridge

Latest news · ONCO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ONCO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on ONCO

Frequently asked questions